Oxalic Acid

Oxalic Acid

SCHEMBL5015074

CC[N+](C)(CC)CC.CC[N+](C)(CC)CC.CC[N+](C)(CC)CC.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(F)C(F)(F)F.O=C(O)C(F)C(F)(F)F.O=C(O)C(F)C(F)(F)F.[O-]B([O-])[O-]

nearest known ligand 0.30

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.30
BBOX1 O75936 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL5022910 0.88 MAPT (0.31) MAPT
Oxalic Acid SCHEMBL5014702 0.83 BBOX1 (0.33) BBOX1
Oxalic Acid SCHEMBL5014695 0.82
Oxalic Acid SCHEMBL5017059 0.79 BBOX1 (0.33) BBOX1
Oxalic Acid SCHEMBL15473640 0.79 MAPT (0.31) MAPT
Oxalic Acid SCHEMBL5017042 0.78 MAPT (0.30) MAPT
Oxalic Acid SCHEMBL27725531 0.75 TSHR (0.35) MAPT
Oxalic Acid SCHEMBL15473580 0.75 ALDH1A1 (0.32) BBOX1
Oxalic Acid SCHEMBL5013723 0.73 BBOX1 (0.33) BBOX1
Oxalic Acid SCHEMBL5015102 0.72 BBOX1 (0.33) BBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8652682-B2 Ionic compound, electrolytic solution, electrochemical device, and battery SONY CORPORATION (JP) 2014-02-18 US disclosed
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY SONY CORPORATION (JP) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY CA2, DUOX2, OTC MAPT 2344/4885BBOX1 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.